Episurf Medical AB (OSTO:EPIS B) Interest Expense : kr-0.70 Mil (TTM As of Jun. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Episurf Medical AB Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Episurf Medical AB's interest expense for the three months ended in Jun. 2025 was kr -0.10 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2025 was kr-0.70 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Episurf Medical AB's Operating Income for the three months ended in Jun. 2025 was kr -17.50 Mil. Episurf Medical AB's Interest Expense for the three months ended in Jun. 2025 was kr -0.10 Mil. Episurf Medical AB did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Episurf Medical AB Interest Expense Historical Data

The historical data trend for Episurf Medical AB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Episurf Medical AB Interest Expense Chart

Episurf Medical AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-0.70

-0.20

-0.70

-0.90

-1.00

Episurf Medical AB Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25
Interest Expense	Get a 7-Day Free Trial															-0.30	-0.20	-0.20	-0.20	-0.10

Episurf Medical AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.70 Mil.

Episurf Medical AB (OSTO:EPIS B) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Episurf Medical AB's Interest Expense for the three months ended in Jun. 2025 was kr-0.10 Mil. Its Operating Income for the three months ended in Jun. 2025 was kr-17.50 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2025 was kr2.90 Mil.

Episurf Medical AB's Interest Coverage for the quarter that ended in Jun. 2025 is calculated as

Episurf Medical AB did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Episurf Medical AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Episurf Medical AB (OSTO:EPIS B) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

0QUT:UK 16E:Germany

Address

Karlavagen 60, Stockholm, SWE, 114 49

Website

https://www.episurf.com

Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint.

Episurf Medical AB Headlines

No Headlines